CDXS
Codexis, Inc.
OpenVolumeMkt capP/EEPSDiv yield
Day – 52-wk –
Expected move
InputsNext report
Last report
Largest filed tie
13F top-10 QoQ
Top fund weight
Codexis, Inc.
Expected move
InputsNext report
Last report
Largest filed tie
13F top-10 QoQ
Top fund weight
Last report1 of 7 at or beyond impliedshaded = implied▲▼ = realized× = |realized| ÷ implied
Codexis, Inc. discovers, develops, and sells enzymes and other proteins. It offers biocatalyst products and services; intermediate chemicals products that are used for further chemical processing; and Codex biocatalyst panels and kits that enable customers to perform chemistry screening. The company also provides biocatalyst screening and protein engineering services. In addition, it offers CodeEvolver protein engineering technology platform, which helps in developing and delivering biocatalysts that perform chemical transformations and enhance the efficiency and productivity of manufacturing processes. The company's platform is also used to discover novel biotherapeutic drug candidates for targeted human diseases, as well as for molecular biology and in vitro diagnostic enzymes. It sells its products to pharmaceutical manufacturers through its direct sales and business development force in the United States and Europe. The company was incorporated in 2002 and is headquartered in Redwood City, California.
Codexis, Inc. discovers, develops, and sells enzymes and other proteins. It offers biocatalyst products and services; intermediate chemicals products that are used for further chemical processing; and Codex biocatalyst panels and kits that enable customers to perform chemistry screening. The company also provides biocatalyst screening and protein engineering services. In addition, it offers CodeEvolver protein engineering technology platform, which helps in developing and delivering biocatalysts that perform chemical transformations and enhance the efficiency and productivity of manufacturing processes. The company's platform is also used to discover novel biotherapeutic drug candidates for targeted human diseases, as well as for molecular biology and in vitro diagnostic enzymes. It sells its products to pharmaceutical manufacturers through its direct sales and business development force in the United States and Europe. The company was incorporated in 2002 and is headquartered in Redwood City, California.
No other changes.
No other changes.
Annual filing, covered
10-K parsed · Mar 11 '26
Supply-chain ties, covered
Disclosed · both directions
Fund holders, covered
N-PORT holdings
13F holdings, covered
13F quarter · Jun 30 '26
Management, not covered
Not covered · DEF 14A, 8-K 5.02
Company IR feed, not covered
News via newswires & EDGAR
Products, patents, hiring, not covered
Not covered
Annual filing, covered
10-K parsed · Mar 11 '26
Supply-chain ties, covered
Disclosed · both directions
Fund holders, covered
N-PORT holdings
13F holdings, covered
13F quarter · Jun 30 '26
Management, not covered
Not covered · DEF 14A, 8-K 5.02
Company IR feed, not covered
News via newswires & EDGAR
Products, patents, hiring, not covered
Not covered
No thesis.
| Manager | Value | % base | |
|---|---|---|---|
| BlackRockindex-like | $16.5M | 11.22% | +3.64% |
| Opaleye | $15.3M | 10.45% | 0.00% |
| Standard Life Aberdeen | $15.3M | 10.43% | −22.01% |
| Millennium | $12.5M | 8.55% | +38.79% |
| Telemark | $8.7M | 5.93% | 0.00% |
| Manager | Value | % base | |
|---|---|---|---|
| BlackRockindex-like | $16.5M | 11.22% | +3.64% |
| Opaleye | $15.3M | 10.45% | 0.00% |
| Standard Life Aberdeen | $15.3M | 10.43% | −22.01% |
| Millennium | $12.5M | 8.55% | +38.79% |
| Telemark | $8.7M | 5.93% | 0.00% |
+8.11%
vs ±34.8% implied · ×0.23
shaded = implied · ▲▼ = realized
Same SIC code · 6
Same SEC industry code: International Flavors & Fragrances Inc, LyondellBasell Industries N.V., Newmarket Corp and 3 more; of Codexis, Inc.'s 6 closest co-movers, none share that code.
Same SIC code · 6
Same SEC industry code: International Flavors & Fragrances Inc, LyondellBasell Industries N.V., Newmarket Corp and 3 more; of Codexis, Inc.'s 6 closest co-movers, none share that code.
Bull2
Bear1
Tall tick = annual report · Source: EDGAR
Codexis, Inc.
1.12
+0.04 · +3.70%
Expected move
Inputsspot 1.08exp Nov 20ATM strike 1ATM straddle 0.50IV 285%